Skip to content

The evaluation of the efficacy of olfactory stimulation as a means of improving cognitive function: A randomised controlled trial

The evaluation of the efficacy of olfactory stimulation as a means of improving cognitive function: A randomised controlled trial - The evaluation of the efficacy of olfactory stimulation as a means of improving cognitive function: A randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032936
Enrollment
120
Registered
2018-06-11
Start date
2019-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy elderly people

Interventions

Odor stimulation by aromas (two hours exposure to odor stimulation twice a day in the morning and evening over three months) Odor stimulation by ethanol (two hours exposure to odor stimulation twice a

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ability to both understand and agree with informed consent in Japanese Ability to perform the all tests required on the designated day after the agreement with informed consent A score of 24 or more on the MMSE Olfactory ability demonstrated as normal by the test of T&T olfactometer

Exclusion criteria

Exclusion criteria: Any substance addiction (except nicotine addiction) in the current or past history Education history of 6 years or less Any substance addiction (except nicotine addiction) in the current or past history Currently receiving any psychotropic medication such as antidepressant, antipsychotics or tranquilizers including sleeping pills Medical history of psychiatric or neurological diseases, including schizophrenia, depressive disorders or anxiety disorders, potentially influencing the olfactory ability (ruled out by the M.I.N.I.(Mini-International Neuropsychiatric Interview) Severe physical disease including liver, renal or endocrine disability Any disease potentially causing the olfactory disability Routinely receiving aromatherapy treatments Routinely using softener, fragrance or perfume with strong smell

Design outcomes

Primary

MeasureTime frame
PASAT(Paced Auditory Serial Addition Test)

Secondary

MeasureTime frame
MMSE, PHQ-9, GAD-7, SDISS,Well-being(the relevant four items from CES-D), RAVLT, Symbol Digit Modalities Test, Pittsburgh Sleep Quality Index, T&T Olfactometer

Countries

Japan

Contacts

Public ContactMika Konishi

Keio University School of Medicine Department of Neuropsychiatry

mikita1204@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026